Italy· 042018010
TEGLUTIK*orale sosp flacone 300 ml 5 mg/ml
A medicinal product containing riluzolo, registered in Italy by ITALFARMACO SpA, on the national reimbursement list.
Checked against the register on
Informational only — not a medical device.
The record
At a glance
- Active substance
- Riluzolo
- Manufacturer
- ITALFARMACO SpA
- Country
- Italy (IT)
- ATC code
- —
- Reimbursed
- Yes
- Last checked
- June 4, 2026
Packs & prices · 1
1 priced- aic042018010TEGLUTIK*orale sosp flacone 300 ml 5 mg/mlEUR 126.83
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Riluzolo in 17 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomEmylif 50mg orodispersible filmsZambon UK Ltd
- CzechiaRILUTEKSanofi Winthrop Industrie, Gentilly
- United StatesriluzoleGlenmark Pharmaceuticals Inc., USA
- GermanyEmylifZambon S.P.A.
- FranceEMYLIF 50 mg, film orodispersibleZAMBON (ITALIE)
- NetherlandsEmylif 50 mg orodispergeerbare filmZambon S.p.A.
- BelgiumEmylif 50 mgZambon
- SwedenGlentek 50 mg Filmdragerad tablettGlenmark Arzneimittel GmbH
Authorised across Europe · EMA
The same active substance is authorised in 25 EEA countries. Names it is sold under:
- Austria · Emylif, Riluzol Aristo
- Belgium · Emylif, Riluzol Ab
- Cyprus · Teglutik
- Czechia · Riluzol Pmcs
- Germany · Emylif, Glentek
- Denmark · Emylif, Glentek
- Estonia · Lizolorol, Rilustad
- Spain · Emylif, Riluzol Aurovitas
- Finland · Teglutik
- France · Emylif, Riluzole Arrow
- United Kingdom (Northern Ireland) · Emylif, Riluzole Accord Healthcare
- Greece · Teglutik
- Croatia · Alsemol
- Hungary · Sclefic
- Iceland · Emylif, Rilutek
- Liechtenstein · Rilutek, Riluzole Zentiva
- Luxembourg · Emylif, Teglutik
- Netherlands · Emylif, Glentek
- Norway · Emylif, Rilutek
- Poland · Riluzol Pmcs, Riluzole Sun
- Portugal · Emylif, Riluzol Aurovitas
- Romania · Riluzol Pmcs
- Sweden · Emylif, Glentek
- Slovenia · Sclefic
- Slovakia · Riluzol Pmcs
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of the issuing authority. This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/829036d1-9771-42c7-b7bb-0898a29cf3bf GET /v1/drugs/829036d1-9771-42c7-b7bb-0898a29cf3bf?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"price": 126.83,
"source": "aifa",
"currency": "EUR",
"strength": "RILUZOLO 300ML 5MG/ML USO ORALE",
"substance": "Riluzolo",
"equivalence_group": "GYK",
"transparency_flag": null
}See everything about riluzolo.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.